Yoshihiro Kinoshita
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Yoshihiro Kinoshita has a total of 19 co-authors. Here are the top co-authors by number of shared publications:
- Toshiaki A. Furukawa
Office of Institutional Advancement and Communications, Kyoto University, Kyoto, Japan
3 shared publications David Kingdon
Department of Psychiatry, University of Southampton, Southampton, UK
2 shared publicationsDavid Dayson
Hampshire Partnership Trust, Southampton, UK
1 shared publicationDeepa Umadi
Hampshire Partnership Trust, Southampton, UK
1 shared publicationDouglas Turkington
Department of Psychiatry, University of Newcastle, Newcastle, UK
1 shared publication- Junwen Chen
The Australian National University, Canberra, Australian Capital Territory, Australia
1 shared publication
Latest Publications
- 8 March 2011
- Published by Springer Nature in Social Psychiatry and Psychiatric Epidemiology
- Vol. 47 (4) , 563-580
A semi-structured clinical interview for psychosis sub-groups (SCIPS): development and psychometric properties
Background Clinical sub-groups of schizophrenia, namely drug related, traumatic, anxiety and stress sensitivity sub-types, have been proposed for use in research, training and practice. They were developed on the basis of clinical observation but have not yet been used in research or clinical practice to any great extent. Aims To develop a semi-structured clinical interview for psychosis sub-groups (SCIPS) and determine the best diagnostic criteria with the highest inter-rater reliability, test–retest reliability and concurrent validity for sub-grouping patients with schizophrenia according to a newly developed classification scheme. Methods The SCIPS was developed based upon discussion with the clinician researchers who had developed and were using the sub-groups. Kappa coefficients were calculated between two independent diagnostic assessments with the SCIPS (for inter-rater reliability and test–retest reliability, n = 20) and between the SCIPS diagnosis and the sub-groupings as determined independently with highest achievable validity (for concurrent validity, n = 21) for patients with schizophrenia. These inter-rater reliability and concurrent validity were compared among five different sets of diagnostic criteria to determine which was most reliable and valid. Results A set of diagnostic criteria with the highest inter-rater reliability and concurrent validity was determined. Kappa coefficients (95% confidence interval) for the inter-rater reliability and concurrent validity were 0.93 (0.66–1.20) and 0.73 (0.47–1.00), respectively, with these diagnostic criteria. Conclusions The SCIPS is a promising tool with which to sub-group patients with schizophrenia according to this recently developed classification scheme. The semi-structured interview achieves acceptable inter-rater and test–retest reliability and concurrent validity.
- 8 March 2011
- Published by Springer Nature in Social Psychiatry and Psychiatric Epidemiology
- Vol. 47 (4) , 563-580
A semi-structured clinical interview for psychosis sub-groups (SCIPS): development and psychometric properties
Background Clinical sub-groups of schizophrenia, namely drug related, traumatic, anxiety and stress sensitivity sub-types, have been proposed for use in research, training and practice. They were developed on the basis of clinical observation but have not yet been used in research or clinical practice to any great extent. Aims To develop a semi-structured clinical interview for psychosis sub-groups (SCIPS) and determine the best diagnostic criteria with the highest inter-rater reliability, test–retest reliability and concurrent validity for sub-grouping patients with schizophrenia according to a newly developed classification scheme. Methods The SCIPS was developed based upon discussion with the clinician researchers who had developed and were using the sub-groups. Kappa coefficients were calculated between two independent diagnostic assessments with the SCIPS (for inter-rater reliability and test–retest reliability, n = 20) and between the SCIPS diagnosis and the sub-groupings as determined independently with highest achievable validity (for concurrent validity, n = 21) for patients with schizophrenia. These inter-rater reliability and concurrent validity were compared among five different sets of diagnostic criteria to determine which was most reliable and valid. Results A set of diagnostic criteria with the highest inter-rater reliability and concurrent validity was determined. Kappa coefficients (95% confidence interval) for the inter-rater reliability and concurrent validity were 0.93 (0.66–1.20) and 0.73 (0.47–1.00), respectively, with these diagnostic criteria. Conclusions The SCIPS is a promising tool with which to sub-group patients with schizophrenia according to this recently developed classification scheme. The semi-structured interview achieves acceptable inter-rater and test–retest reliability and concurrent validity.
- Open Access
- 14 October 2010
- Published by Springer Nature in BMC Psychiatry
- Vol. 10 (1) , 81
Change in quality of life and their predictors in the long-term follow-up after group cognitive behavioral therapy for social anxiety disorder: a prospective cohort study
Social anxiety disorder (SAD) is one of the most common anxiety disorders. The efficacy of cognitive behaviour therapy (CBT) has been examined but to date its effects on Quality of Life (QoL) have not been appropriately evaluated especially in the long term. The study aimed to examine, in the long term, what aspects of Quality of Life (QoL) changed among social anxiety disorder (SAD) patients treated with group cognitive behaviour therapy (CBT) and what predictors at baseline were associated with QoL. Outpatients diagnosed with SAD were enrolled into group CBT, and assessed at follow-ups for up to 12 months in a typical clinical setting. QoL was evaluated using the Short Form 36. Various aspects of SAD symptomatology were also assessed. Each of the QoL domains and scores on symptomatology were quantified and compared with those at baseline. Baseline predictors of QoL outcomes at follow-up were investigated. Fifty-seven outpatients were enrolled into group CBT for SAD, 48 completed the whole program, and 44 and 40 completed assessments at the 3-month and 12-month follow-ups, respectively. All aspects of SAD symptomatology and psychological subscales of the QoL showed statistically significant improvement throughout follow-ups for up to 12 months. In terms of social functioning, no statistically significant improvement was observed at either follow-up point except for post-treatment. No consistently significant pre-treatment predictors were observed. After group CBT, SAD symptomatology and some aspects of QoL improved and this improvement was maintained for up to 12 months, but the social functioning domain did not prove any significant change statistically. Considering the limited effects of CBT on QoL, especially for social functioning, more powerful treatments are needed.
- 14 October 2010
- Published by Springer Nature in BMC Psychiatry
- Vol. 10 (1) , 81
Open AccessChange in quality of life and their predictors in the long-term follow-up after group cognitive behavioral therapy for social anxiety disorder: a prospective cohort study
Social anxiety disorder (SAD) is one of the most common anxiety disorders. The efficacy of cognitive behaviour therapy (CBT) has been examined but to date its effects on Quality of Life (QoL) have not been appropriately evaluated especially in the long term. The study aimed to examine, in the long term, what aspects of Quality of Life (QoL) changed among social anxiety disorder (SAD) patients treated with group cognitive behaviour therapy (CBT) and what predictors at baseline were associated with QoL. Outpatients diagnosed with SAD were enrolled into group CBT, and assessed at follow-ups for up to 12 months in a typical clinical setting. QoL was evaluated using the Short Form 36. Various aspects of SAD symptomatology were also assessed. Each of the QoL domains and scores on symptomatology were quantified and compared with those at baseline. Baseline predictors of QoL outcomes at follow-up were investigated. Fifty-seven outpatients were enrolled into group CBT for SAD, 48 completed the whole program, and 44 and 40 completed assessments at the 3-month and 12-month follow-ups, respectively. All aspects of SAD symptomatology and psychological subscales of the QoL showed statistically significant improvement throughout follow-ups for up to 12 months. In terms of social functioning, no statistically significant improvement was observed at either follow-up point except for post-treatment. No consistently significant pre-treatment predictors were observed. After group CBT, SAD symptomatology and some aspects of QoL improved and this improvement was maintained for up to 12 months, but the social functioning domain did not prove any significant change statistically. Considering the limited effects of CBT on QoL, especially for social functioning, more powerful treatments are needed.
- 26 July 2008
- Published by Springer Nature in Social Psychiatry and Psychiatric Epidemiology
- Vol. 44 (2) , 104-108
Hallucinations in visually impaired individuals
Objective Charles Bonnet syndrome (CBS) is by complex visual hallucinations and ocular pathology causing vision loss. It has been considered that CBS occurs frequently in elderly visually handicapped patients and the hallucinations are limited to the visual modality. Three hypotheses we examined were: (1) whether visual impairments are associated with visual hallucinations (2) whether visual impairments are associated with auditory hallucinations (3) whether the development of visual and auditory hallucinations in patients with visual impairments is associated with age. Method Data from the National Comorbidity Survey Replication (NCS-R) in the United States were used to examine whether associations between visual impairments and visual hallucinations can be found in the general population, and whether such influences of visual impairments are limited to the visual modality and to specific age groups. Results Prevalence of visual and auditory hallucinations in respondents with visual impairments were 12.8% (95% Confidence Interval (CI) = 3.4–22.2%) and 7.1% (95%CI = 2.6–11.6%) respectively. Although the point estimates were substantive, the odds ratios between visual impairments and existence of visual hallucinations or auditory hallucinations were not statistically significant (odds ratio (OR) = 2.43, 95%CI = 0.92–6.44, P = 0.07 and OR = 2.16, 95%CI = 0.87–5.33, P = 0.10, respectively) in the whole sample. Association between visual impairments and visual hallucination was significant (OR = 3.09, 95%CI = 1.06–8.99, P < 0.05) only in the elderly (age group 60-), while significant association was found between visual impairments and auditory hallucinations in a younger age group (age group 18–39, OR = 13.25, 95%CI = 2.99–58.75, P < 0.001). Conclusion Visual impairments act as a trigger for both visual and auditory hallucinations. In patients with visual impairments, the presence of visual hallucinations was associated with an age over 60, while the existence of auditory hallucinations was associated with an age under 39.
- 26 July 2008
- Published by Springer Nature in Social Psychiatry and Psychiatric Epidemiology
- Vol. 44 (2) , 104-108
Hallucinations in visually impaired individuals
Objective Charles Bonnet syndrome (CBS) is by complex visual hallucinations and ocular pathology causing vision loss. It has been considered that CBS occurs frequently in elderly visually handicapped patients and the hallucinations are limited to the visual modality. Three hypotheses we examined were: (1) whether visual impairments are associated with visual hallucinations (2) whether visual impairments are associated with auditory hallucinations (3) whether the development of visual and auditory hallucinations in patients with visual impairments is associated with age. Method Data from the National Comorbidity Survey Replication (NCS-R) in the United States were used to examine whether associations between visual impairments and visual hallucinations can be found in the general population, and whether such influences of visual impairments are limited to the visual modality and to specific age groups. Results Prevalence of visual and auditory hallucinations in respondents with visual impairments were 12.8% (95% Confidence Interval (CI) = 3.4–22.2%) and 7.1% (95%CI = 2.6–11.6%) respectively. Although the point estimates were substantive, the odds ratios between visual impairments and existence of visual hallucinations or auditory hallucinations were not statistically significant (odds ratio (OR) = 2.43, 95%CI = 0.92–6.44, P = 0.07 and OR = 2.16, 95%CI = 0.87–5.33, P = 0.10, respectively) in the whole sample. Association between visual impairments and visual hallucination was significant (OR = 3.09, 95%CI = 1.06–8.99, P < 0.05) only in the elderly (age group 60-), while significant association was found between visual impairments and auditory hallucinations in a younger age group (age group 18–39, OR = 13.25, 95%CI = 2.99–58.75, P < 0.001). Conclusion Visual impairments act as a trigger for both visual and auditory hallucinations. In patients with visual impairments, the presence of visual hallucinations was associated with an age over 60, while the existence of auditory hallucinations was associated with an age under 39.